Hereditary Angioedema Prophylaxis: Surveying the Next Wave of Therapies

The goal of this activity is to improve clinicians' knowledge regarding physiologic targets for hereditary angioedema (HAE) prophylaxis and data on emerging agents.

Target Audience

This activity is intended for allergists & clinical immunologists, primary care physicians, and dermatologists.

Learning Objectives

Upon completion of this activity, participants should be able to:

Demonstrate increased knowledge regarding the pathophysiology of HAE and targets for prophylaxis

Describe clinical trial data on investigational approaches to HAE prophylaxis

Summary
Available credit: 
  • 0.25 Attendance
    Attendance credit.
  • 0.25 CME
    CME credit.
Course opens: 
05/23/2019
Course expires: 
05/23/2020
Cost:
$0.00
Part of: 
Hereditary Angioedema: Integrating the Full Circle– Interprofessional Care, Patient Perspectives, and Emerging Treatment Options
Rating: 
0
Faculty

William Lumry, MD
Clinical Professor of Internal Medicine, University of Texas Southwestern Medical School
Medical Director, AARA Research Center (Private Practice), Dallas, Texas
Disclosure: William Lumry, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Adverum; BioCryst Pharmaceuticals, Inc.; CSL Behring; Optum RX; Pharming Group NV; Shire; Served as a speaker or a member of a speakers bureau for: CSL Behring; Genentech, Inc.; Optinose Rengeneron; Sanofi; Shire
Received grants for clinical research from: BioCryst Pharmaceuticals, Inc.; CSL Behring; Genentech, Inc.; Green Cross; Menlo; NeRRE; Novartis Pharmaceuticals Corporation; Octapharma; Sanofi; Shire; Teva Pharmaceuticals USA; Therapure

Editors

Roderick Smith, MS
Medical Education Director, Medscape, LLC
Disclosure: Roderick Smith, MS, has disclosed no relevant financial relationships.

Tina Greco, PharmD
Medical Writer
Disclosure: Tina Greco, PharmD, has disclosed the following relevant financial relationships: Owns stock, stock options, or bonds from: Novartis Pharmaceuticals Corporation; Employed by a commercial interest: Indivior Pharmaceuticals

Content Reviewers, AAAAI

Steven Folstein, MEd
Director of Education, American Academy of Allergy, Asthma & Immunology
Disclosure: Steven Folstein, MEd, has disclosed no relevant financial relationships.

Brian Schroer, MD
Disclosure: Brian Schroer, MD, has disclosed no relevant financial relationships.

Content Reviewer

Esther Nyarko, PharmD
Associate CME Clinical Director, Medscape, LLC
Disclosure: Esther Nyarko, PharmD, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAAI and Medscape LLC. The AAAAI is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit Claiming Period

Credit claiming for this activity will expire at 11:59 pm on May 8, 2020. Requests to claim credit on or after May 9, 2020 will be denied.

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.

  2. Study the educational content online or printed out.

  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

AAAAI Privacy Policy

To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.

Questions

For questions regarding the content of this activity, contact cme@aaaai.org for this CME/CE activity noted above. For technical assistance, contact CME@medscape.net

Available Credit

  • 0.25 Attendance
    Attendance credit.
  • 0.25 CME
    CME credit.

Price

Cost:
$0.00
Please login or register to take this course.